Heart Failure Disease Management Program in Skilled Nursing Facilities for Reduced Rehospitalizations and Mortality
This study aims to determine if a heart failure disease management program can reduce hospitalizations, emergency department visits, and mortality within 60 days for heart failure patients in skilled nursing facilities, compared to usual care.
Heart Failure Disease Management Program
+ Heart Failure Usual Care
Cardiovascular Diseases
+ Heart Diseases
+ Heart Failure
Prevention Study
Summary
Study start date: January 1, 2013
Actual date on which the first participant was enrolled.Heart failure patients who are discharged to skilled nursing facilities face higher risks of rehospitalization and mortality compared to those who return home. Currently, there are no national guidelines for heart failure disease management programs in skilled nursing facilities, despite evidence that such programs can reduce rehospitalizations in community settings. This study aims to evaluate the impact of a heart failure disease management program on patients' outcomes within 30 days post-admission to a skilled nursing facility, with a focus on preventing rehospitalizations, emergency room visits, and mortality. Patients participating in this study will be cared for either through a specialized heart failure disease management program or usual care. The program consists of seven components designed to manage heart failure effectively. The study's primary outcome is to measure the difference in the composite endpoint of 60-day all-cause hospitalization, all-cause emergency department visits, and all-cause mortality between patients in skilled nursing facilities who receive care via the disease management program versus usual care.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.713 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
Active ComparatorGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location